Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $957,692 - $1.1 Million
-12,172 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $389,635 - $495,835
-5,435 Reduced 30.87%
12,172 $1.11 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $1.06 Million - $1.38 Million
-15,805 Reduced 47.3%
17,607 $1.4 Million
Q2 2020

Aug 13, 2020

SELL
$57.54 - $76.95 $26.7 Million - $35.7 Million
-463,955 Reduced 93.28%
33,412 $2.3 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $26.1 Million - $40.3 Million
497,367 New
497,367 $93.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.